Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Refractory Multiple Myeloma
We found longer OS and PFS in patients with a complete response before allo-SCT. This shows that the depth of response before allogeneic stem cell transplantation is effective on 100-day TRM in multiple myeloma patients. Allo-HSCT may be a therapeutic option in MM patients who relapse/refractory after auto-SCT, particularly after achieving the least partial response.
Authors
- Ferda Can (ORCID: https://orcid.org/0000-0002-9899-1441)
- ZA Yeğin
- Leylagül Kaynar (ORCID: https://orcid.org/0000-0002-2035-9462)
- HBA Öztürk
- ZN Özkurt
- AA Dikyar
Institutions
- Memorial Ankara Hospital (TR)
- Ankara Bilkent City Hospital (TR)
- Gazi University (TR)
Publication Details
- Journal
- Nigerian Journal of Clinical Practice
- Published
- 2024-12-01
- DOI
- https://doi.org/10.4103/njcp.njcp_107_24
- Citations
- 2
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.91